Muneyuki Masuda - Concepedia

Author

Muneyuki Masuda

Also Known As

M MASUDA, M Masuda, M. Masuda, M. Masuda,, MASUDA, M., MUNEYUKI MASUDA, Masafumi Masuda, Milena Mak, Minoru Masuda, Mitsunobu Masuda

280

Publications

Citations

H-Index

125

Concepts

All Affiliations

Kyushu University National Hospital Organization Kyushu Cancer Center Kyushu Hospital Columbia University Saga University

About

Muneyuki Masuda is an author at Kyushu University specializing in medicine, cancer research, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	34	1.9K
2	Engineering	6	6	207
3	Health Sciences	6	6	271
4	Social Sciences	1	1	17
5	Allergy	1	1	36

Muneyuki Masuda

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Muneyuki Masuda, Masumi Suzui, Ryuji Yasumatu, PubMed Hnscc CellsSignal TransducersImmunologyPathologyCancer Biology	2002	379
Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Muneyuki Masuda, Masumi Suzui, I. Bernard Weinstein PubMed Chemoprevention StrategyPathologyCell DeathCell ProliferationCell Cycle	2001	319
Epigallocatechin‐3‐gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR‐related pathways of signal transduction Muneyuki Masuda, Masumi Suzui, Jin T. E. Lim, Journal of Experimental Therapeutics and Oncology	2002	232
Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Muneyuki Masuda, Masumi Suzui, Jin T. E. Lim, PubMed Breast OncologyChemoprevention StrategyDownstream Signaling PathwaysCancer BiologyTumor Biology	2003	156
Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Masumi Suzui, Muneyuki Masuda, Jin T. E. Lim, PubMed Chemoprevention StrategyAcyclic RetinoidCyclin D1PathologyCell Death	2002	123
YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma Hirofumi Omori, Miki Nishio, Muneyuki Masuda, Science Advances	2020	115
Cyclin D1 overexpression in primary hypopharyngeal carcinomas Muneyuki Masuda, Naoya Hirakawa, Torahiko Nakashima, Cancer	1996	96
Relationship between immune-related adverse events and the long-term outcomes in recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab Mioko Matsuo, Ryuji Yasumatsu, Muneyuki Masuda, Oral Oncology MedicineImmunologyImmune Checkpoint InhibitorRecurrent/metastatic HeadHead And Neck Cancer	2019	91
Prevalence of Human Papillomavirus in Oropharyngeal Cancer: A Multicenter Study in Japan Takanori Hama, Yutaka Tokumaru, Masato Fujii, Oncology	2014	89
Characteristics of the Salivary Microbiota in Patients With Various Digestive Tract Cancers Shinya Kageyama, Toru Takeshita, Kenji Takeuchi, Frontiers in Microbiology	2019	89

Page 1